Obesity and diabetes are currently a major health problem worldwide with growing in prevalence. Obesity and diabetes induce secondary diseases with various pathophysiologic states including cardiovascular disease, neural disturbance, kidney disease, cancer and osteoporosis. Bone homeostasis is maintained through a delicate balance between osteoblastic bone formation and osteoclastic bone resorption. Aging and numerous pathological processes induce decrease in osteoblastic bone formation and increase in osteoclastic bone resorption, leading to osteoporosis with decrease in bone mass. Osteoblasts and adipocytes differentiate from a common precursor cell in the bone marrow mesenchymal stem cells. Type 1 and obese type 2 diabetes have been associated with increased fracture risk. Nutritional chemical factors are found to prevent diabetic osteoporosis. Zinc, Satsuma mandarin orange (Citrus unshiu MARC.) β-cryptoxanthin and plant component p-hydroxycinnamic acid was found to reveal stimulatory effects on osteoblastic bone formation and suppressive effects on osteoclastic bone resorption, thereby increasing bone mass. These factors were found to improve type 1 diabetic bone loss in vivo. Moreover, p-hydroxycinnamic acid suppressed adipogenesis in bone marrow cells in vitro. Such functional food factors may improve bone loss implicated with type 1diabetes and obese type 2 diabetes.